# The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity

> **NCT07271771** · PHASE4 · RECRUITING · sponsor: **Aarhus University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Denosumab
- **DRUG:** Saline (0.9% NaCl)

## Key facts

- **NCT ID:** NCT07271771
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-21
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07271771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07271771, "The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07271771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*